Randomized analysis shows improved financial performance in 340B hospitals, suggesting effective use of resources.
Key Points
To investigate the financial performance changes in hospitals eligible for the 340B program, particularly in relation to their use of program-generated revenue.
Analyzed Medicare Cost Reports and Office of Pharmacy Affairs data from 2023 for 340B-eligible hospitals (excluding critical access hospitals)
Used descriptive statistics and linear regressions to assess financial performance metrics
Compared performance measures between 340B and non-340B hospitals
340B hospitals had 47.5% greater total assets than non-340B hospitals (95% CI: 36.7% to 58.3%)
10 additional 340B sites contributed to a 0.15% increase in real asset growth rate (95% CI: 0.05% to 0.25%)